Furthermore, future exploration of possible epigenetic regulation and crosstalk between genetic PON variants and DNA methylation could provide deeper insights into the mechanisms contributing to clinical MASLD phenotype [23,65]. The gene discussed is PON1; the disease is metabolic dysfunction-associated steatotic liver disease.